Macromolecules of Natural and Synthetic Origin for Progress Drug Delivery in Photodynamic Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 September 2024 | Viewed by 64
Special Issue Editor
Interests: macroheterocyclic molecules; photosensitizers; fluorescent molecules; photochemical mechanisms; singlet oxygen; fluorescent diagnosis; photodynamic therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The curative method photodynamic therapy (PDT) as a local, with low general toxicity and non-invasive for humans is currently in clinics. The drug delivery limitations of photoactive compounds often induce side effects which can be limited with novel innovative delivery systems. These can be structures from natural or synthetic origin, or with low toxicity, target-specific functionality, high uptake capacity to the targets and fast release after procedure.
This Special Issue aims to provide a scientific platform for scientists with different research interests who are currently interested in drug delivery. The chemistry of the novel substances as vehicles, mechanisms of uptakes, native bioorganic molecule role in accumulation and delivery, and other factors with a critical role in prompt delivery and release that are of concern for PDT response, are the welcome topics.
All efforts made by scientists in synthesis, photochemistry, phytochemistry, biophysics and photobiology to report and publish their latest results, and the scientific community to let us know the up-to-date innovative achievements in the drug delivery systems or/ and molecules for PDT and related fields are of interest, with my cordial appreciation to all colleagues and friends who wish to submit research papers, communications and reviews to the Special Issue.
Dr. Vanya Mantareva
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- macromolecules
- photoactive compounds
- natural products
- photosensitizers
- drug delivery systems
- photochemistry
- phytochemistry
- photodynamic therapy
- green PDT approach
